CLINICAL_TRIALS ClinicalTrials.gov record update

Safety and Immunogenicity Study of GSK Biologicals' Measles-mumps-rubella (MMR) Vaccine (209762) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine, in Healthy Children 12 to 15 Months of Age

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02184572
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:37:52.446913+00:00
Published At: 2018-07-03T00:00:00+00:00
Record Updated At: 2021-01-07
Results Posted At: 2018-07-03
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Measles; Mumps; Rubella", "Measles-Mumps-Rubella Vaccine"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2021-01-07"
protocolSection.identificationModule.nctId: "NCT02184572"
protocolSection.identificationModule.officialTitle: "Safety and Immunogenicity Study of GSK Biologicals\u0027 Measles-mumps-rubella (MMR) Vaccine (209762) Comparing Immunogenicity and Safety to Merck \u0026 Co., Inc.\u0027s MMR Vaccine, in Healthy Children 12 to 15 Months of Age"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2018-07-03"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.